Comparison of Gene Enrichment Between Prostate Tissue and Urine for Non-Invasive Biomarker Development.
BACKGROUND For prostate cancer (PCa), early diagnosis and biomarker-based patient stratification can improve clinical decision-making and post-treatment prognosis. PCa biomarkers are best validated in tissue following comprehensive histopathologic review; however, urinary biomarkers can be obtained non-invasively and a...